Neurocognitive impairment is frequently encountered in Multiple Sclerosis (MS) patients affecting between 40-65% of these individuals, irrespective of disease duration, severity of physical disability, and at both the earlier and later disease stages, with a tendency to worsen over time.


Read full article on news-medical.net